Article Details

Lirentelimab effective for refractory chronic urticaria - Hospital Healthcare Europe

Retrieved on: 2022-02-14 07:14:03

Tags for this article:

Click the tags to see associated articles and topics

Lirentelimab effective for refractory chronic urticaria - Hospital Healthcare Europe. View article details on hiswai:

Excerpt

Lirentelimab is an anti-sialic acid binding immunoglobulin-like lectin 8 monoclonal antibody which appears effective in chronic urticaria.

Article found on: hospitalhealthcare.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up